Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 295
- Evidence Id
- 295
- Core Evidence Id
- 295
- Source Clinical Trial Id
- 281
- Herb2 Clinical Trial Id
- HBCT000281
- Nct Id
- NCT03677583
- Title
- Duckweed Intake Study
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Gastrointestinal Complication
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
- Intervention
- OTHER: Duckweed|OTHER: Spinach
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Other
- Gender
- All
- Age
- Adult
- Enrollment
- 24
- Outcome Measure
- change in gastro-intestinal complaints, bloated feeling, belching, abdominal pain, flatulence, nausea, diarrhoea, constipation measured via Visual Analogue Scale (VAS), Daily, during 11 days of duckweed intake and up to three days after intake. By questionnaires and Visual Analogue Scale (VAS) scores; from no complains (minimal) to serious complains (maximum)). Higher values represent a worse outcome
- Sponsor Collaborator
- Wageningen University and Research
- Funded By
- OTHER
- Location
- Stichting Wageningen Research, Wageningen, Gelderland, 6708 WG, Netherlands
- Other Id
- NL66051.081.18
- Start Date
- 2018-10-01
- Primary Completion Date
- 2018-10-14
- Completion Date
- 2018-10-15
- First Posted
- 2018-09-19
- Results First Posted
- Last Update Posted
- 2018-10-22
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03677583
- Title Cn
- Title En
- Duckweed Intake Study
- Bilingual Status
- semi_complete